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Glaucoma is the second leading cause of blindness in the United
States and the leading cause of blthdness in African Americans.
Early detection and treatment can prevent blindness.
Glaucoma as we understand it today represents a group of disease
entities which have as a final common pathway damage to the optic
nerve and as a consequence, visual field loss. These changes can
result in blindness. Traditionally, the glaucomas were classified
simply as primary, secondary, combined or congenital. However, it
is now clear that glaucoma is a much more complicated disease.
In recent years, the study of molecular genetics have opened new
areas of understanding glaucoma. Juvenile open angle glaucoma,
primary infantile glaucoma and other developmental glaucomas
have been determined to have a molecular basis. With increasing
knowledge in these areas, the classification of the glaucomas will be
partially based on the findings of the defective gene or gene
products. Primary open angle glaucoma, the most common form of
glaucoma, may eventually be subdivided genotypically into many
different diseases.’ In these cases, gene therapy may offer a new
treatment modality.
Glaucoma is the second leading cause of blindness in the United
States and the leading cause of blindness in African Americans. The
most common form of glaucoma, primary open angle glaucoma, is
a major health problem with 2 million Americans having this
disease. Half of these Americans may not be aware that they have
this disease.2More than 7 million office visits occur per year with
the primary diagnosis to monitor patients with glaucoma and
patients at risk for developing glaucoma.3About 80,000 Americans
are legally blind from glaucoma and many more have severe visual
impairment.
Primary open angle glaucoma accounts for 70% of the glaucoma
cases in the United States.4Important risk factors include the level
of intraocular pressure, race and age. The prevalence of primary
open angle glaucoma increases with increasing intraocular pres
sure. Primate studies and observations in angle closure and second
ary glaucomas provide good evidence that elevated intraocular
pressure can lead to optic nerve damage. However, significant
individual variation exists in correlating the optic neuropathy and
intraocular pressure. Studies show only one-tenth or less of those
with elevated intraocular pressure have glaucomatous field loss.5
About one-sixth of patients with glaucomatous optic nerve damage
with field loss have less than 21 mmHg intraocular pressure even
after repeated measurements.
Several factors may cause the progressive optic neuropathy of
primary open angle glaucoma besides the intraocular pressure but
the intraocular pressure is treatable and therefore treatments have
included medications, laser surgery or other surgical treatments.
This is a reasonable approach to therapy for this condition because
progressive field defects occur in patients with higher intraocular
pressures.6
African Americans have a prevalence of 4 to 5 times greater than
other races, making race an important risk factor in primary open
angle glaucoma. Compared to Caucasian Americans, blindness due
to glaucoma is 4 to 8 times greater in African Americans.2Japanese
appear to have a higher prevalence of low tension glaucoma.
Age is another important risk factor for primary open angle
glaucoma. The Baltimore Eye Survey demonstrated this. African
Americans 80 years or older have a prevalence exceeding 11%.
Family history of glaucoma is a risk factor. The risk ofdeveloping
glaucoma is at least 3 times greater in patients who have a sibling
with primary open angle glaucoma.
Other risk factors which have not shown consistency include
cardiovascular disease, hypertension, diabetes and myopia.7
Besides measuring intraocularpressures, screening ofpatients for
primary open angle glaucoma must include an assessment of the
optic nerve status. This can be done by direct observation of the
optic nerve or nerve fiber layer or by an analysis of the visual fields.
Visual field defects may not be noted until one-third or more of the
optic nerve fibers have been destroyed. Glaucoma can be suspected
if the intraocular pressure exceeds 21 mmHg or the vertical cup/disc
ratio of the optic nerve head is greater than 0.5. Intraocularpressure
measurement alone cannot be relied on to make the diagnosis of
primary open angle glaucoma. Therefore, probably the more effi
cient way to detect and diagnose primary open angle glaucoma is a
routine periodic comprehensive eye examination.3
The examination for glaucoma must include the family history,
ocular history and systemic disease history. A history of prior eye
injury or diseases may give clues to the etiology of the glaucoma. A
strong family history might suggest a genetic link while the pres
ence of some systemic diseases like pseudoexfoliation syndrome
might correlate with the presence of glaucoma.
The ocular examination must include the recording of visual
acuity. The pupillary responses must be checked for any afferent
pupillary defect. A Goldmann type applanation tonometer is pref
erable to measure the intraocular pressure. The time of the pressure
measurement should be recorded as diurnal variations may influ
ence the pressure measurements. Sometimes diurnal measurements
may be necessary in those cases where the severity of the optic nerve
damage does not correlate with the normal or less than normal
intraocular pressure.
The slit lamp examination of the anterior ocular segments, gonios
copy to determine open or narrow angle, optic disc and nerve fiber
layer evaluation and fundus examination are part of the glaucoma
evaluation. (Fig. I ) The optic nerve appearance can be described but
photographs of the optic nerve head and if available, stereophotog
raphy, are preferred methods of documenting the optic nerve head.
HAWAII MEDICAL JOURNAL, VOL 56, SEPTEMBER 1997
235
(Fig. 2) When photography is unavailable, a careful drawing of the
optic nerve head is appropriate.8
The examination of the fundus may reveal information that could
explain certain visual field defects. Automatic static threshold
techniques are useful methods to record reproducible defects in the
fields of vision.
Arcuate scotoma typically is formed in advanced glaucoma. Since
primary open angle glaucoma is a chronic and often, asymptomatic
disease, noncompliance in the use of medications may have a
significant impact on the glaucoma control.9Medications are ex
pensive and often produce significant side effects and even can
cause death. Medications include epinephrine, miotics, beta blockers,
alpha agonists, carbonic anhydrase inhibitors, and prostaglandins.
Marijuana may reduce intraocular pressure but it is not more
effective than the available medications. It may also have signifi
cant side effects.
Other treatment modalities include laser therapy and glaucoma
surgery. The most commonly used filtering operation is
trabeculectomy which creates a fistula to allow the aqueous to leave
the eye. In complicated cases, posterior tube shunts are inserted into
the eye to drain the aqueous. Antifibrosis agents like 5-fluorouracil
or Mitomycin-C can often improve the success rates in glaucoma
filtering operations. When treatment modalities have failed,
cyclodestructive procedures that destroy the ciliary body and its
processes may be utilized. Laser or cryosurgery is available for
cyclodestruction.
The life-styles of glaucoma patients can be seriously affected.
Peer support can be helpful and constant encouragement is neces
sary for patients taking medications for a generally asymptomatic
disease. Because ofpossible systemic side effects, other health care
providers must have knowledge of the glaucoma medications being
used. Life-style areas which can be affected may include loss of
independence, hobbies, sports, financial, sexuality, reading, driving
and job loss.
Angle closure glaucoma accounts for 10% of glaucoma cases in
the United States. Predisposing factors include persons with ana
tomically narrow angles as determined by gonioscopy. Hyperopia,
Asians and Eskimos, the elderly, women and a family history of this
condition are other predisposing factors.4The patient may present
with a painful red eye, nausea, vomiting, blurred vision and seeing
halos around lights. The cornea is hazy due to edema and the pupil
is sernidilated. Gonioscopy will reveal the closed angle and the
intraocular pressure will be greatly elevated. (Fig. 3)
Angle closure glaucoma requires emergency treatment which
may include topical, oral and intravenous medications. After the
pressure is stabilized, a peripheral iridotomy with laser is done.
Because there may be a 78% chance of the unaffected eye develop
ing acute glaucoma, a prophylactic laser iridotomy is done on the
unaffected eye. ‘°
Glaucomas with related ocular conditions are termed secondary
glaucomas. These include trauma. uveitis, diabetic retinopathy,
vein occlusions and long term use of steroids.11 Retinal ischemia as
a result of diabetic retinopathy or occlusive disease may result in
new blood vessels growing into and obstructing the trabecular
meshwork. This can result in neovascular glaucoma, a difficult
glaucoma to treat. Ocular developmental abnormalities can lead to
congenital and infantile glaucoma. In this group, symptoms can
Fig. 3—Acute Glaucoma I
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include cornea! enlargement, epiphora, photo
phobia, blepharospasm, and corneal edema.
The preferred treatment in congenital and in
fantile glaucoma is surgery. Medical manage
ment usually has a limited long-term value.
In summary, glaucoma is a unique oph
thalmic disease. Before treatment, the patient
may have been totally asymptomatic. Major
effects on the quality of life can occur once
therapy is initiated. Medical therapy may be
life long but untreated, the disease in its natural
course may result in blindness. Surgery can be
offered to patients if the disease progresses and
the patient becomes intolerant to medications.
An ongoing assessment of the quality of life is
an essential portion of the management of the
glaucoma patient.
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